KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Co-Diagnostics (CODX) Cost of Revenue (2017 - 2025)

Historic Cost of Revenue for Co-Diagnostics (CODX) over the last 9 years, with Q3 2025 value amounting to $568937.0.

  • Co-Diagnostics' Cost of Revenue fell 4631.38% to $568937.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.7 million, marking a year-over-year decrease of 4877.55%. This contributed to the annual value of $4.5 million for FY2024, which is 3465.3% down from last year.
  • Per Co-Diagnostics' latest filing, its Cost of Revenue stood at $568937.0 for Q3 2025, which was down 4631.38% from $609713.0 recorded in Q2 2025.
  • Co-Diagnostics' Cost of Revenue's 5-year high stood at $5.9 million during Q2 2021, with a 5-year trough of $568937.0 in Q3 2025.
  • Over the past 5 years, Co-Diagnostics' median Cost of Revenue value was $1.6 million (recorded in 2024), while the average stood at $1.9 million.
  • Per our database at Business Quant, Co-Diagnostics' Cost of Revenue surged by 57932.18% in 2021 and then plummeted by 7484.8% in 2022.
  • Co-Diagnostics' Cost of Revenue (Quarter) stood at $2.1 million in 2021, then crashed by 36.46% to $1.3 million in 2022, then rose by 14.04% to $1.5 million in 2023, then crashed by 46.04% to $818669.0 in 2024, then crashed by 30.5% to $568937.0 in 2025.
  • Its Cost of Revenue was $568937.0 in Q3 2025, compared to $609713.0 in Q2 2025 and $657030.0 in Q1 2025.